{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:19:14Z","timestamp":1767061154868,"version":"3.48.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00428-025-04106-5","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T09:42:21Z","timestamp":1745487741000},"page":"1371-1381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Residual disease volume and prognosis in endometrioid precancer after progestin therapy"],"prefix":"10.1007","volume":"487","author":[{"given":"Fei","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rujia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruijiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glorimar","family":"Rivera-Colon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenling","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0457-0097","authenticated-orcid":false,"given":"Wanrun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"issue":"1","key":"4106_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17\u201348","journal-title":"CA Cancer J Clin"},{"key":"4106_CR2","unstructured":"Common cancer types.https:\/\/www.cancer.gov\/types\/common-cancers [https:\/\/www.cancer.gov\/types\/common-cancers]"},{"issue":"4","key":"4106_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/j.semdp.2010.09.007","volume":"27","author":"EA Jarboe","year":"2010","unstructured":"Jarboe EA, Mutter GL (2010) Endometrial intraepithelial neoplasia. Semin Diagn Pathol 27(4):215\u2013225","journal-title":"Semin Diagn Pathol"},{"key":"4106_CR4","doi-asserted-by":"publisher","unstructured":"Yi X, Zheng W (2008) Endometrial glandular dysplasia and endometrial intraepithelial neoplasia. Curr Opin Obstet Gynecol 20(1):20\u201325. https:\/\/doi.org\/10.1097\/GCO.0b013e3282f2fd50","DOI":"10.1097\/GCO.0b013e3282f2fd50"},{"issue":"5","key":"4106_CR5","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1097\/AOG.0b013e31826bb121","volume":"120","author":"CL Trimble","year":"2012","unstructured":"Trimble CL, Method M, Leitao M, Lu K, Ioffe O, Hampton M, Higgins R, Zaino R, Mutter GL (2012) Management of endometrial precancers. Obstet Gynecol 120(5):1160\u20131175","journal-title":"Obstet Gynecol"},{"issue":"37","key":"4106_CR6","doi-asserted-by":"publisher","first-page":"e8034","DOI":"10.1097\/MD.0000000000008034","volume":"96","author":"J Wei","year":"2017","unstructured":"Wei J, Zhang W, Feng L, Gao W (2017) Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: a meta-analysis and systematic review. Medicine 96(37):e8034","journal-title":"Medicine"},{"issue":"1","key":"4106_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ygyno.2011.11.043","volume":"125","author":"J Baker","year":"2012","unstructured":"Baker J, Obermair A, Gebski V, Janda M (2012) Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature. Gynecol Oncol 125(1):263\u2013270","journal-title":"Gynecol Oncol"},{"issue":"5","key":"4106_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/jcp.20.5.731","volume":"20","author":"JG Azzopardi","year":"1967","unstructured":"Azzopardi JG, Zayid I (1967) Synthetic progestogen-oestrogen therapy and uterine changes. J Clin Pathol 20(5):731\u2013738","journal-title":"J Clin Pathol"},{"issue":"7","key":"4106_CR9","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.humpath.2010.11.003","volume":"42","author":"J Fiscella","year":"2011","unstructured":"Fiscella J, Bonfiglio T, Winters P, Eisinger SH, Fiscella K (2011) Distinguishing features of endometrial pathology after exposure to the progesterone receptor modulator mifepristone. Hum Pathol 42(7):947\u2013953","journal-title":"Hum Pathol"},{"issue":"2","key":"4106_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/1066896906299120","volume":"15","author":"RK Hejmadi","year":"2007","unstructured":"Hejmadi RK, Chaudhri S, Ganesan R, Rollason TP (2007) Morphologic changes in the endometrium associated with the use of the mirena coil: a retrospective study of 106 cases. Int J Surg Pathol 15(2):148\u2013154","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"4106_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/modpathol.2008.19","volume":"21","author":"GL Mutter","year":"2008","unstructured":"Mutter GL, Bergeron C, Deligdisch L, Ferenczy A, Glant M, Merino M, Williams AR, Blithe DL (2008) The spectrum of endometrial pathology induced by progesterone receptor modulators. Mod Pathol 21(5):591\u2013598","journal-title":"Mod Pathol"},{"issue":"6","key":"4106_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/PGP.0000000000000450","volume":"37","author":"FF Nogales","year":"2018","unstructured":"Nogales FF, Crespo-Lora V, Cruz-Viruel N, Chamorro-Santos C, Bergeron C (2018) Endometrial changes in surgical specimens of perimenopausal patients treated with ulipristal acetate for uterine leiomyomas. Int J Gynecol Pathol 37(6):575\u2013580","journal-title":"Int J Gynecol Pathol"},{"issue":"9","key":"4106_CR13","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/1471-0528.13763","volume":"123","author":"A Orbo","year":"2016","unstructured":"Orbo A, Arnes M, Vereide AB, Straume B (2016) Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens. BJOG 123(9):1512\u20131519","journal-title":"BJOG"},{"issue":"5","key":"4106_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/00006254-199505000-00026","volume":"50","author":"JY Song","year":"1995","unstructured":"Song JY, Fraser IS (1995) Effects of progestogens on human endometrium. Obstet Gynecol Surv 50(5):385\u2013394","journal-title":"Obstet Gynecol Surv"},{"key":"4106_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/978-981-13-3016-2_15","volume-title":"Quick CM edit Gynecologic and Obstetric Pathology The","author":"GC Tan","year":"2019","unstructured":"Tan GC (2019) TY K: Cyclin endometrium and exogenous hormone effect. In: Zheng W, Shen D, Guo D, Fadare O (eds) Quick CM edit Gynecologic and Obstetric Pathology The, 1st edn. Switzerland, Springer, pp 383\u2013408","edition":"1"},{"issue":"7","key":"4106_CR16","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1097\/PAS.0b013e31802d68ce","volume":"31","author":"DT Wheeler","year":"2007","unstructured":"Wheeler DT, Bristow RE, Kurman RJ (2007) Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol 31(7):988\u2013998","journal-title":"Am J Surg Pathol"},{"key":"4106_CR17","doi-asserted-by":"publisher","unstructured":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. The writing group for the PEPI Trial. JAMA 275(5):370\u2013375. https:\/\/doi.org\/10.1001\/jama.1996.03530290040035","DOI":"10.1001\/jama.1996.03530290040035"},{"issue":"10","key":"4106_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.mpdhp.2023.07.006","volume":"29","author":"E Lucas","year":"2023","unstructured":"Lucas E, Chen H, Sahoo SS, Carrick K, Grubman J, Zheng W, Hecht J, Castrillon DH (2023) \u03b2-catenin, PAX2 and PTEN panel in the diagnosis of endometrial precancers: a case-based review. Diagn Histopathology 29(10):468\u2013482. https:\/\/doi.org\/10.1016\/j.mpdhp.2023.07.006","journal-title":"Diagn Histopathology"},{"issue":"9","key":"4106_CR19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/PAS.0000000000002076","volume":"47","author":"E Lucas","year":"2023","unstructured":"Lucas E, Niu S, Aguilar M, Molberg K, Carrick K, Rivera-Colon G, Gwin K, Wang Y, Zheng W, Castrillon DH (2023) Utility of a PAX2, PTEN, and \u03b2-catenin panel in the diagnosis of atypical hyperplasia\/endometrioid intraepithelial neoplasia in endometrial polyps. Am J Surg Pathol 47(9):1019\u20131026. https:\/\/doi.org\/10.1097\/PAS.0000000000002076","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4106_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/PAS.0000000000001810","volume":"46","author":"M Aguilar","year":"2022","unstructured":"Aguilar M, Chen H, Rivera-Colon G, Niu S, Carrick K, Gwin K, Cuevas IC, Sahoo SS, Li HD, Zhang S et al (2022) Reliable identification of endometrial precancers through combined Pax2, beta-catenin, and Pten immunohistochemistry. Am J Surg Pathol 46(3):404\u2013414","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"4106_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/PAS.0000000000002034","volume":"47","author":"M Aguilar","year":"2023","unstructured":"Aguilar M, Chen H, Sahoo SS, Zheng W, Grubman J, SoRelle JA, Lucas E, Castrillon DH (2023) beta-catenin, Pax2, and Pten panel identifies precancers among histologically subdiagnostic endometrial lesions. Am J Surg Pathol 47(5):618\u2013629","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"4106_CR22","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1097\/PAS.0000000000001537","volume":"44","author":"H Chen","year":"2020","unstructured":"Chen H, Lucas E, Strickland AL, Carrick K, Gwin K, Castrillon DH, Rivera-Colon G, Niu S, Molberg KH, Zheng W (2020) Specific biomarker expression patterns in the diagnosis of residual and recurrent endometrial precancers after progestin treatment: a longitudinal study. Am J Surg Pathol 44(10):1429\u20131439","journal-title":"Am J Surg Pathol"},{"key":"4106_CR23","first-page":"250","volume":"4","author":"S Lax","year":"2020","unstructured":"Lax S, Mutter GL (2020) Endometrial atypical hyperplasia\/endometrioid intraepithelial neoplasia. Female Genital Tumours WHO Classification of Tumours Series 4:250\u2013251","journal-title":"Female Genital Tumours WHO Classification of Tumours Series"},{"issue":"2","key":"4106_CR24","first-page":"154","volume":"5","author":"RJ Zaino","year":"1988","unstructured":"Zaino RJ, Kurman RJ (1988) Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma. Semin Diagn Pathol 5(2):154\u2013171","journal-title":"Semin Diagn Pathol"},{"issue":"15","key":"4106_CR25","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-10-0149","volume":"70","author":"NM Monte","year":"2010","unstructured":"Monte NM, Webster KA, Neuberg D, Dressler GR, Mutter GL (2010) Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. Cancer Res 70(15):6225\u20136232","journal-title":"Cancer Res"},{"issue":"5","key":"4106_CR26","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1309\/AJCP8OMLT7KDWLMF","volume":"138","author":"CM Quick","year":"2012","unstructured":"Quick CM, Laury AR, Monte NM, Mutter GL (2012) Utility of PAX2 as a marker for diagnosis of endometrial intraepithelial neoplasia. Am J Clin Pathol 138(5):678\u2013684","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"4106_CR27","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/apm.12988","volume":"127","author":"A Travaglino","year":"2019","unstructured":"Travaglino A, Raffone A, Saccone G, Mascolo M, D\u2019Alessandro P, Arduino B, Mollo A, Insabato L, Zullo F (2019) Nuclear expression of beta-catenin in endometrial hyperplasia as marker of premalignancy. APMIS 127(11):699\u2013709","journal-title":"APMIS"},{"issue":"2","key":"4106_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.anndiagpath.2006.06.009","volume":"11","author":"Y Norimatsu","year":"2007","unstructured":"Norimatsu Y, Moriya T, Kobayashi TK, Sakurai T, Shimizu K, Tsukayama C, Ohno E (2007) Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women. Ann Diagn Pathol 11(2):103\u2013108","journal-title":"Ann Diagn Pathol"},{"issue":"20","key":"4106_CR29","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.3390\/jcm10204784","volume":"10","author":"U Leone Roberti Maggiore","year":"2021","unstructured":"Leone Roberti Maggiore U, Khamisy-Farah R, Bragazzi NL, Bogani G, Martinelli F, Lopez S, Chiappa V, Signorelli M, Ditto A, Raspagliesi F (2021) Fertility-sparing treatment of patients with endometrial cancer: a review of the literature. J Clin Med 10(20):4784","journal-title":"J Clin Med"},{"issue":"11","key":"4106_CR30","doi-asserted-by":"publisher","first-page":"5613","DOI":"10.1158\/0008-5472.CAN-05-4321","volume":"66","author":"A \u00d8rbo","year":"2006","unstructured":"\u00d8rbo A, Rise CE, Mutter GL (2006) Regression of latent endometrial precancers by progestin infiltrated intrauterine device. Can Res 66(11):5613\u20135617","journal-title":"Can Res"},{"issue":"1","key":"4106_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3892\/ol.2012.975","volume":"5","author":"S Zhao","year":"2013","unstructured":"Zhao S, Li G, Yang L, Li L, Li H (2013) Response-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate. Oncol Lett 5(1):139\u2013144","journal-title":"Oncol Lett"},{"issue":"1","key":"4106_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41420-023-01319-y","volume":"9","author":"L Wei","year":"2023","unstructured":"Wei L, Ma X, Hou Y, Zhao T, Sun R, Qiu C, Liu Y, Qiu Z, Liu Z, Jiang J (2023) Verteporfin reverses progestin resistance through YAP\/TAZ-PI3K-Akt pathway in endometrial carcinoma. Cell Death Discovery 9(1):30","journal-title":"Cell Death Discovery"},{"issue":"6","key":"4106_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/GCO.0000000000000819","volume":"34","author":"S Liu","year":"2022","unstructured":"Liu S, Kciuk O, Frank M, Tyson N (2022) Progestins of today and tomorrow. Curr Opin Obstet Gynecol 34(6):344\u2013350","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"6","key":"4106_CR34","doi-asserted-by":"publisher","first-page":"e12763","DOI":"10.1002\/rth2.12763","volume":"6","author":"C LaVasseur","year":"2022","unstructured":"LaVasseur C, Neukam S, Kartika T, Bannow BS, Shatzel J, DeLoughery TG (2022) Hormonal therapies and venous thrombosis: considerations for prevention and management. Research and Practice in Thrombosis and Haemostasis 6(6):e12763","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"issue":"6","key":"4106_CR35","first-page":"982","volume":"92","author":"GA Greendale","year":"1998","unstructured":"Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, Barrett-Connor E (1998) Investigators PEPIT: Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen\/Progestin Interventions Trial. Obstet Gynecol 92(6):982\u2013988","journal-title":"Obstet Gynecol"},{"issue":"3","key":"4106_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3802\/jgo.2019.30.e49","volume":"30","author":"Y Wang","year":"2019","unstructured":"Wang Y, Nisenblat V, Tao L, Zhang X, Li H, Ma C (2019) Combined estrogen-progestin pill is a safe and effective option for endometrial hyperplasia without atypia: a three-year single center experience. J Gynecol Oncol 30(3):100. https:\/\/doi.org\/10.3802\/jgo.2019.30.e49","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"4106_CR37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/PAS.0000000000001810","volume":"43","author":"M Aguilar","year":"2021","unstructured":"Aguilar M, Chen H, Rivera-Colon G, Niu S, Carrick K, Gwin K, Cuevas HC, Sahoo SS, Li HD, Zhang S et al (2021) Reliable identification of endometrial precancers through combined Pax2 \u03b2-catenin, and Pten immunohistochemistry. Am J Surg Pathol 43(3):404\u2013414. https:\/\/doi.org\/10.1097\/PAS.0000000000001810","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4106_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1053\/j.semdp.2021.10.001","volume":"39","author":"RJ Chang","year":"2022","unstructured":"Chang RJ, Rivera-Colon G, Chen H, Niu S, Carrick K, Lucas E, Gwin K, Zheng W (2022) Navigating through perplex morphologic changes after exogenous hormone usage. Semin Diagn Pathol 39(3):148\u2013158","journal-title":"Semin Diagn Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04106-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04106-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04106-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:06:37Z","timestamp":1767060397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04106-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4106"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04106-5","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"type":"print","value":"0945-6317"},{"type":"electronic","value":"1432-2307"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient consent was waived due to the reason that the current study does not require patient consent since only residual tissues in the paraffin blocks were used after clinical diagnosis and management were completed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study was conducted in accordance with ethical standards, and approval was obtained from the appropriate institutional and\/or national ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}